Review Article

Animal Models of Diabetic Macrovascular Complications: Key Players in the Development of New Therapeutic Approaches

Table 4

Atherosclerotic mouse models with increased atherosclerosis after genetically induced diabetes.

Mouse modelDietHyperlipidemiaAtherosclerosisCommentsReference

Diabetes increases atherosclerosis without changes in plasma lipids
LDLR−/−GPTC (8.8 mM)
TG (2.1 mM)
↑ × 3[139]
ApoE−/−IRS2−/−WD
(9–12 wks)
TC (64.9 mM)
TG (0.8 mM)
[140]
ApoE−/−IRS2−/−AD
(4 wks)
TC (15.6 mM)[141]
ApoE−/−Insr+/−Irs1+/−WD
(15 wks)
TC (24.0–30.9 mM)
TG (1.1–1.5 mM)
[44]

Diabetes increases atherosclerosis and alters plasma lipid levels
LDLR−/−ob/obTC↑ (44.5 mM)
TG↑ (11.5 mM)
[38]
LDLR−/−GPAD
(12 wks)
TC↑ (34.9 mM)
TG↑ (23.8mM)
↑ × 2Lesion hemorrhages↑[139]
LDLR−/−ob/obTC↑ (17.2 mM)
TG↑ (3.4 mM)
↑ × 4[36]
LDLR−/−ApoB100/100ob/obTC↑ (44.8 mM)
TG↑ (7.4 mM)
Versus C57Bl/6: Insulin↑, BP↑[39]
ApoE−/−db/dbTC↑ (15.1 mM)
TG↑ (2.6 mM)
↑ × 3[37]
ApoE−/−db/dbWD
(10 wks)
TC↑ (37.9 mM)
TG↑ (10.1 mM)
[37]
ApoE−/−db/dbTC↑ (24.8 mM)
TG (0.2 mM)
↑ × 3[142]
ApoE−/−db/dbChow dietTC↑ (30–40 mM)
TG (1-2 mM)
↑ × 3-4C57BL/6 background*
ApoE−/−ob/obTC↑ (17.7 mM)
TG (1.5 mM)
↑ × 3[36]
ApoE−/−ApoB100/100ob/obTC↑ (31.2 mM)
TG↑ (3.8 mM)
Versus C57Bl/6: glucose↑, insulin↑, IR, BP↑ [39]
LDLR−/−Ins2AkitaHCD
(16 wks)
TC↑ (32.5 mM)
TG↑ (5.3 mM)
↑ × 2Phenotype stronger in males[25]
ApoE−/−Ins2AkitaTC↑ (22.5 mM)
TG↑ (0.9 mM)
↑ × 3[24]
E4hLDLR-tg
Ins2Akita
TC↑ (2.6 mM)
TG (0.5 mM)
Non-HDL-C/HDL-C ratio~3[143]
KKAy+ApoE−/−TC↑ (7.6 mM)
TG↑ (1.3 mM)
[41]
Trail−/−ApoE−/−WD
(12 wks)
TC↑ (23 mM)
TG↑ (2.2 mM)
[144]

AD, atherogenic diet (10.8–40% energy from fat, 0.075–1.5% cholesterol, possibly with 0.5% sodium cholate); BP, blood pressure; E4, human ApoE*4 allele; HCD, high-cholesterol diet (20% energy from fat, 0.15–1.25% cholesterol); hLDLR, human LDLR; TC, total cholesterol; TG, triglycerides; WD, Western diet (Harlan Teklad TD96125 or TD88137). *Hübschle T, Hiss K. unpublished data.